EP1620735A1 - Secreted polypeptide species reduced in cardiovascular disorders - Google Patents

Secreted polypeptide species reduced in cardiovascular disorders

Info

Publication number
EP1620735A1
EP1620735A1 EP04729080A EP04729080A EP1620735A1 EP 1620735 A1 EP1620735 A1 EP 1620735A1 EP 04729080 A EP04729080 A EP 04729080A EP 04729080 A EP04729080 A EP 04729080A EP 1620735 A1 EP1620735 A1 EP 1620735A1
Authority
EP
European Patent Office
Prior art keywords
cpp
polypeptide
amino acid
level
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04729080A
Other languages
German (de)
English (en)
French (fr)
Inventor
Lydie Bougueleret
Samia Reffas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Genova Ltd
Original Assignee
Novartis Pharma GmbH
Genova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH, Genova Ltd filed Critical Novartis Pharma GmbH
Publication of EP1620735A1 publication Critical patent/EP1620735A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
EP04729080A 2003-04-25 2004-04-23 Secreted polypeptide species reduced in cardiovascular disorders Withdrawn EP1620735A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46536903P 2003-04-25 2003-04-25
PCT/EP2004/004350 WO2004097424A1 (en) 2003-04-25 2004-04-23 Secreted polypeptide species reduced in cardiovascular disorders

Publications (1)

Publication Number Publication Date
EP1620735A1 true EP1620735A1 (en) 2006-02-01

Family

ID=33418234

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04729080A Withdrawn EP1620735A1 (en) 2003-04-25 2004-04-23 Secreted polypeptide species reduced in cardiovascular disorders

Country Status (3)

Country Link
EP (1) EP1620735A1 (ja)
JP (1) JP2006526578A (ja)
WO (1) WO2004097424A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019825A2 (en) * 2003-08-20 2005-03-03 Genova Ltd. Secreted polypeptide species and use thereof
US8193312B2 (en) * 2004-01-28 2012-06-05 The Regents Of The University Of California Bone morphogenic protein binding peptide
WO2005072403A2 (en) 2004-01-28 2005-08-11 The Regents Of The University Of California Bone morphogenic protein binding peptide
US8415302B2 (en) 2004-01-28 2013-04-09 The Regents Of The University Of California Surgical applications for BMP binding protein
US8753660B2 (en) 2004-11-29 2014-06-17 The Regents Of The University Of California Activating extraction of demineralized bone matrix
US9072709B2 (en) 2009-06-23 2015-07-07 The Regents Of The University Of California Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
US9797912B2 (en) * 2013-06-28 2017-10-24 Newsouth Innovations Pty Limited Diagnostic method for inflammatory bowel disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021006A1 (en) * 1995-01-06 1996-07-11 The Regents Of The University Of California Novel phosphoprotein secreted in the extracellular matrices of mammalian organs and methods for use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004097424A1 *

Also Published As

Publication number Publication date
JP2006526578A (ja) 2006-11-24
WO2004097424A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
US20070082363A1 (en) Secreted polypeptide species reduced cardiovascular disorders
US20080227125A1 (en) Secreted Polypeptide Species Reduced in Cardiovascular Disorders
US20070009955A1 (en) Secreted polypeptide species associated with cardiovascular disorders
WO2005015206A2 (en) Secreted polypeptide species associated with cardiovascular disorders
JP2005533086A5 (ja)
EP1620735A1 (en) Secreted polypeptide species reduced in cardiovascular disorders
EP1634086A2 (en) Secreted polypeptide species associated with cardiovascular disorders
WO2006029838A2 (en) Secreted polypeptide species involved in alzheimer’s disease
WO2006005586A2 (en) New polypeptide species specific to cerebrospinal fluid
US20070128664A1 (en) Secreted polypeptide species associated with cardiovascular disorders
WO2004090551A2 (en) Secreted polypeptide species associated with cardiovascular disorders
US20070105169A1 (en) Secreted polypeptide species associated with cardiovascular disorders
US20070098635A1 (en) Secreted polypeptide species associatedwith cardiovascular disorders
WO2006005585A2 (en) Secreted polypeptide species differentially expressed during pregnancy
WO2004101615A2 (en) Secreted polypeptide species associated with cardiovascular disorders
EP1642138A1 (en) Secreted polypeptide species reduced in cardiovascular disorders
CA2512629A1 (en) Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders
WO2005003161A2 (en) Human secreted proteins
US20060147447A1 (en) Secreted peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071101